End repair rewrites DNA. TrueLink® preserves it.

Protect native templates, retain real biology, and reduce sequencing costs.

PROBLEM STATEMENT

End-repair based NGS library prep rewrites template DNA: erasing real biology; creating artificial errors; and failing to capture mixed template populations.

IMPACT

  • True mutations disappear

  • Synthetic errors introduced

  • Unusable molecules (chimeras) emerge

  • Native terminal structure destroyed

  • Single-stranded molecules drop out

  • Epigenetic signals lost

TECHNOLOGY

TrueLink® - Library prep without compromise.

TrueLink® leverages proprietary enzymes and adapters in a unique, simultaneous dual-ligation workflow where sequencing adapters attach directly to the native termini. No writing, no erasing, no splints, and no lost signals.

TrueLink® safeguards every DNA molecule, unveiling true genomic insights.

ABOUT CANAL BIOSCIENCES

Canal Biosciences is advancing genomics through improved DNA library preparation technologies.

Our proprietary TrueLink® platform preserves DNA template integrity, increasing genomic data accuracy while improving the efficiency and economics of DNA sequencing.

Our mission: Deliver best in class library prep workflows to power the high-precision NGS applications of the future.

Rooted in Lowell’s iconic canal district, Canal Biosciences carries forward Massachusetts’ legacy of turning industrial ingenuity into modern biotechnology.

MEET THE CANAL TEAM

Yu
Zheng

Founder & Co-CEO

Chris
Benoit

Co-CEO

Jack
Percoskie

CFO

Matt
Hims

VP of R&D

Gary
Teeters

Development Scientist

Dawn
Ciulla

Scientist